Mechanistic studies have linked macrophage subsets to transcriptional programs and MPN subtype-specific pathologies, with CD163 correlating positively with hemoglobin in PV, platelets in ET, and negatively with hemoglobin in PMF [8]. Here, CD163 is linked to myeloproliferative neoplasm.